Charles River Laboratories International financial statements

찰스 리버 래브러토리스 인터내셔널NYSE:CRL · New York Stock Exchange · Healthcare · sector #13
$310.77+7.09%
2026-10-05 close

Charles River Laboratories International's published financial data is dated 2026-10-04. 2024 revenue was $4.05B. 2024 operating profit was $227M.

Reported results

Charles River Laboratories International notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q